4 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34853102 | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19. | 2021 Dec 1 | 1 |
2 | 23464532 | Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin. | 2013 Aug | 2 |
3 | 23522182 | Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus. | 2013 Oct | 2 |
4 | 22943931 | Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp. | 2012 Nov | 3 |